NCT00359008View on ClinicalTrials.gov

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

CompletedOBSERVATIONAL

Enrollment

336

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

September 30, 2007

Conditions

Age Related Macular Degeneration

Trial Locations (1)

18101

Ha'emek Hospital, Afula

Sponsors

Lead Sponsor

Notal Vision Ltd.

All Listed Sponsors

lead

Notal Vision Ltd.

INDUSTRY

NCT00359008 - PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) | Biotech Hunter | Biotech Hunter